Noda.My understanding is that Acadia is committed to do the Phase 3 trials of trofinetide for both retts and fragile X so the money they are investing say $180 mill is substantially more than our capitalisation of $120 million and Neuren still owns the row rights for trofinetide and NNZ2591 .At the end of December they had about $660 mill aussie in the bank so funding should not be a problem .This is just a waiting game until the market wakes up to its potential.
Noda.My understanding is that Acadia is committed to do the...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |